Drug targeting inflammation helps improve the effects of stroke

Share this article:

A new delivery method for a drug delivered to the central nervous system holds hope for treating brain inflammation that comes after a stroke, researchers have found. The effect can be realized years after a stroke, they said.

The drug, etanercept, has been successful in treating other inflammatory diseases, such as rheumatoid arthritis. The drug works by neutralizing tumor necrosis factor, a cytokine that initiates and amplifies inflammation.

When etanercept was administered to three stroke patients, all demonstrated improvement in areas such as motor function, gait, hand function, sensory deficits, spatial perception, speech and cognition within 10 minutes. The results of the study were published in Tuesday's issue of CNS Drugs.
Share this article:

More in News

Expert says providers often wrongly threatened by PEPPER reports

Instead of fearing further scrutiny by federal authorities, providers should embrace the opportunity to get feedback in the form of PEPPER reports, legal experts said Monday at the LeadingAge annual meeting in Nashville.

Healthcare reform already driving diverse, dynamic long-term care models, LeadingAge leaders say

Healthcare reform already driving diverse, dynamic long-term care ...

One way to gauge the effects is healthcare reform is by looking at ongoing changes to the continuing care retirement community model, LeadingAge officials said Monday at the association's annual ...

Federal court: Nursing home can be sued for firing hairdresser who can ...

Is the ability to transport residents in their wheelchairs an essential function of a nursing home hairdresser? A federal appeals court says it's a valid question and is allowing a hairdresser to sue a facility that fired her.